ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

NCT05056896 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
161
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators